A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir
NCT00002251 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2005-06-24
Summary
This study is designed to determine the influence of food on the absorption and relative bioavailability of oral ganciclovir by comparing the absorption of oral ganciclovir in a fed and fasting state at steady state plasma levels.
Conditions
- Cytomegalovirus Infections
- HIV Infections
Interventions
- DRUG
-
Ganciclovir
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 13 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS
NCT00002273 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS
NCT00002257 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV
NCT00001034 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection
NCT01602614 ·Status: COMPLETED
-
A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002330 ·Status: COMPLETED ·Phase: NA
-
An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access
NCT00002135 ·Status: COMPLETED ·Phase: NA
-
A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection
NCT00000995 ·Status: COMPLETED ·Phase: NA
-
The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial
NCT00566072 ·Status: COMPLETED ·Phase: NA
-
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
NCT00530218 ·Status: COMPLETED ·Phase: PHASE2
-
Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR
NCT00004573 ·Status: UNKNOWN ·Phase: NA
-
Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
NCT00002024 ·Status: COMPLETED ·Phase: NA
-
A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy
NCT00002247 ·Status: COMPLETED ·Phase: NA
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
NCT00001062 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study Comparing the Efficacy of Ganciclovir as a Function of Blood Exposure to the Drug During a Curative or Preemptive Treatment
NCT03088553 ·Status: UNKNOWN
-
A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis
NCT00002134 ·Status: COMPLETED ·Phase: NA
-
A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.
NCT00001100 ·Status: COMPLETED ·Phase: PHASE3
-
Neonatal CMV-Ganciclovir Follow-up Study
NCT00031421 ·Status: COMPLETED
-
Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease
NCT00002145 ·Status: COMPLETED ·Phase: PHASE3
-
(Val)Ganciclovir TDM in Transplant Recipients
NCT03698435 ·Status: UNKNOWN
-
A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )
NCT00002156 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes
NCT00002356 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
NCT00002025 ·Status: COMPLETED ·Phase: NA
-
Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients
NCT00373165 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients
NCT01769170 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers
NCT02454699 ·Status: COMPLETED ·Phase: PHASE1